指南与共识呼吸衰竭与机械通气重症综合管理与镇静镇痛

COVID-19患者经皮与外科气管切开的多中心比较及未来资源利用建议

Open versus percutaneous tracheostomy in COVID-19: a multicentre comparison and recommendation for future resource utilisation.
指南 / 共识 · Eur Arch Otorhinolaryngol · 2021-01-09
一句话结论COVID-19机械通气患者行经皮扩张气管切开与外科气管切开在围术期并发症、拔管时间和死亡率上无差异。

这项多中心多学科回顾性观察性队列研究纳入南伦敦成人重症监护网络5家NHS信托ICU中201例需机械通气并后续行气管切开的COVID-19肺炎患者,比较经皮扩张气管切开(124例,62%)与外科气管切开(77例,38%)的结局。两组围术期并发症率(16.9% vs 22.1%,p=0.46)、拔管时间中位数[19.0(15.0-30.2(5.0-65.0))天 vs 21.0(15.5-36.0(5.0-70.0))天]和死亡率(13.7% vs 15.6%,p=0.84)均无差异。随访时172例存活者中2例仍通气、163例已拔管。作者认为未来COVID-19相关重症监护需求激增的规划应利用所有可用资源和专长。

要点

  • COVID-19肺炎机械通气需气管切开者,经皮扩张气管切开与外科气管切开的围术期并发症率无差异(16.9% vs 22.1%,p=0.46)。
  • 两种气管切开方式的拔管时间中位数无差异:经皮组19.0(15.0-30.2(5.0-65.0))天 vs 外科组21.0(15.5-36.0(5.0-70.0))天。
  • 两种气管切开方式的死亡率无差异:经皮组13.7% vs 外科组15.6%(p=0.84)。
  • 随访时172例存活者中2例仍通气、163例已拔管。
  • 作者认为未来COVID-19相关重症监护需求激增的规划应利用所有可用资源和专长。

适用人群与场景

  • 南伦敦成人重症监护网络5家NHS信托ICU中需机械通气并后续行气管切开的COVID-19肺炎患者,共201例。

研究设计与关键结果

  • 多中心多学科回顾性观察性队列研究,纳入201例COVID-19肺炎机械通气后行气管切开的ICU患者。
  • 经皮扩张气管切开124例(62%),外科气管切开77例(38%)。
  • 围术期并发症率:经皮扩张气管切开16.9% vs 外科气管切开22.1%(p=0.46),无差异。
  • 拔管时间中位数[IQR(范围)]:经皮扩张气管切开19.0(15.0-30.2(5.0-65.0))天 vs 外科气管切开21.0(15.5-36.0(5.0-70.0))天,无差异。
  • 死亡率:经皮扩张气管切开13.7% vs 外科气管切开15.6%(p=0.84),无差异。
  • 随访时172例存活者中2例仍通气,163例已拔管。

证据类型、等级与局限

  • 证据类型:多中心多学科回顾性观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,未来COVID-19相关重症监护需求激增的规划应利用所有可用资源和专长,不应仅依赖单一气管切开方式。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: The COVID-19 pandemic placed an unprecedented demand on critical care services for the provision of mechanical ventilation. Tracheostomy formation facilitates liberation from mechanical ventilation with advantages for both the patient and wider critical care resource, and can be performed using both percutaneous dilatational and surgical techniques. We compared outcomes in those patients undergoing percutaneous dilatational tracheostomy to those undergoing surgical tracheostomy and make recommendations for provision of tracheostomy services in any future surge.

METHODS: Multicentre multidisciplinary retrospective observational cohort study including 201 patients with COVID-19 pneumonitis admitted to an ICU in one of five NHS Trusts within the South London Adult Critical Care Network who required mechanical ventilation and subsequent tracheostomy.

RESULTS: Percutaneous dilatational tracheostomy was performed in 124 (62%) of patients, and surgical tracheostomy in 77 (38%) of patients. There was no difference between percutaneous dilatational tracheostomy and surgical tracheostomy in either the rate of peri-operative complications (16.9 vs. 22.1%, p = 0.46), median [IQR(range)] time to decannulation [19.0 (15.0-30.2 (5.0-65.0)] vs. 21.0 [15.5-36.0 (5.0-70.0) days] or mortality (13.7% vs. 15.6%, p = 0.84). Of the 172 patients that were alive at follow-up, two remained ventilated and 163 were decannulated.

CONCLUSION: In patients with COVID-19 pneumonitis that require tracheostomy to facilitate weaning from mechanical ventilation, there was no difference in outcomes between those patients that had percutaneous dilatational tracheostomy compared with those that had surgical tracheostomy. Planning for future surges in COVID-19-related critical care demands should utilise all available resource and expertise.

来源:Eur Arch Otorhinolaryngol,查看原文。版权归原作者所有。

参考来源

  1. Rovira A, Tricklebank S, Surda P, et al. Open versus percutaneous tracheostomy in COVID-19: a multicentre comparison and recommendation for future resource utilisation. Eur Arch Otorhinolaryngol. 2021. PMID: 33420842. doi:10.1007/s00405-020-06597-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。